ZHONGSHAN INVESTMENT OPPORTUNITIES 中山投资推介会

The Chinese-American Bio/Pharmaceutical Society (CABS) is a non-profit organization for professionals in the biopharmaceutical industry. CABS is headquartered in San Francisco Bay Area, California. This is the home of the Silicon Valley, the birthplace of biotechnology and one of the largest biomedical cluster with the highest venture capital investment in the world. There are more than a thousand biopharmaceutical/biotech companies in this area, including several large biopharmaceuticals such as Amgen, Genentech and Gilead. CABS is a highly influential association with more than 3000 members and subscribers in the life sciences industry. About 70% of our members have PhD degree relating to life sciences. A considerable proportion of the members are holding senior research and management positions in American and multi-national life sciences corporations. Many of our members are experts and leaders, innovative entrepreneurs, lawyers and venture capitalists or investors in the life sciences sector. CABS is the largest and most active Chinese biopharmaceutical association in Northern America. We organize many activities to promote Sino-US collaborations in life sciences and to provide Science & Technology Parks and life sciences companies in China with an excellent platform to promote business and to recruit talent. In addition to year-round technology and business seminars, the annual BioPacific Conference organized by CABS is a highly anticipated event that attracts hundreds of biopharmaceutical professionals and business leaders.Website: www.cabsweb.org

Chinese-American Bio/Pharmaceutical Society

Supporting Pillars, Success Story &amp; Funding Opportunities by Zhongshan Municipal Gov’t 
Zhongshan Municipal People’s Government will host “Zhongshan Investment Opportunities Promotion Seminar” on Dec 15, 5:00pm-8:00pm, at Junior Ballroom of Marriott Oakland City Center. We cordially invite you and your colleagues to attend this event. 
Besides Mayor of Zhongshan and the delegates, the event will also attract other local officials including California State Officials, Alameda County Officials, Mayor of Oakland, city council members and a lot of representatives of biotech/pharma companies.
Zhongshan is the hometown of Dr. Sun Yat-sen, the great forerunner of China’s democratic revolution. In 2016, the city’s per capita GDP reached $15,000; the total size of R&D investment topped USD ~$1 billion with 7,597 filed patent applications, accounting for 2.4% of the total GDP.  In addition, there are 882 high-tech enterprises and 42 post-Ph.D work stations. It also nested over 160 universities and research institutions.  The National Health Technology Park in Zhongshan is one of the first national health industrial park in China, which had generated about $6 Billion USD output in 2016.  Besides Novartis Group, Ferring, A&Z and other globally well-known pharmaceutical companies, it is also the home for hundreds of biotech/pharma and medical devices companies.
The success of Akeso Bio Pharma is considered a natural outcome from the park incubator program.  The company focuses on discovering and developing innovative biologics with international intellectual rights for the treatment of a broad spectrum of diseases, especially in co-developing antibody drugs with strategic partners.  Following its A-round seeding investment in July 2015, it soon secured the collaboration with Merck for R&D and commercialization of an immune checkpoint blocking antibody AK107, which lead to as much as $200M USD milestone payment.
We sincerely invite you to attend this limited-seat event, where you could have opportunity to meet and talk with the government officials as well as other associates.  The tentative agenda is listed below for your reference.
17:00 – 17:30 Registration 17:30 – 17:50 Keynote speech 17:50 – 18:10 Presentation on Zhongshan investment opportunities 18:10 – 18:30 Success story sharing 18:30 Dinner &amp; Networking 
中山市人民政府将于2017年12月15日（周五）下午5-8pm在美国加州奥克兰市万豪酒店举行“中山市投资环境推介会”，并于会后宴请与会嘉宾。出席此次活动的主要人员有中山市市长及随行代表团、加州州立政府官员、Alameda县政府官员、奥克兰市长、市议员及其他来自湾区生物技术和生物制药领域的同行们。会议将介绍中山市的投资环境，同时康方生物CEO夏瑜博士将分享他们在中山市的成长历程，康方生物是从中山园区孵化器中成长的一个典型案例，公司成立于2012年，2015年就与默沙东达成一项肿瘤免疫疗法的单克隆抗体药物AK107的研究、开发和推广的协议，按照协议康方生物将得到总价为2亿美元的里程碑付款，夏博士将分享做为海归人员回国开发新药的经验和建议。我们诚挚邀请您注册参加此次活动。名额有限，报名从速！
·      17:00 – 17:30 注册 ·      17:30 – 17:50 主要领导发言 ·      17:50 – 18:10 中山投资环境介绍 ·      18:10 – 18:30 康方生物公司介绍成功经验 ·      18:30 – 晚餐及交流

Junior Ballroom on 2nd Floor at Marriott Oakland City Center

Our {communityGuidelinesLink} describe the sort of content we prohibit on Eventbrite. If you suspect an event may be in violation, you can report it to us so we can investigate.

To report other categories of prohibited or illegal content, submit {link}